Copyright © 2004, European Society of Cardiology
Myocardial contraction is 5-fold more economical in ventricular than in atrial human tissue
aLaboratory for Physiology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, van der Boechorststraat 7, 1081BT Amsterdam, The Netherlands
bDepartment of Cardiology, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, Amsterdam, The Netherlands
cDepartment of Cardiac Surgery, Institute for Cardiovascular Research (ICaR-VU), VU University Medical Center, Amsterdam, The Netherlands
dThorax Center, Erasmus MC, Rotterdam, The Netherlands
* Corresponding author. Tel.: +31 20 444 8121; fax: +31 20 444 8255. Email address: na.narolska{at}vumc.nl
Objective: Cardiac energetics and performance depend on the expression level of the fast (
-) and slow (β-) myosin heavy chain (MHC) isoform. In ventricular tissue, the β-MHC isoform predominates, whereas in atrial tissue a variable mixture of - and β-MHC is found. In several cardiac diseases, the slow isoform is upregulated; however, the functional implications of this transition in human myocardium are largely unknown. The aim of this study was to determine the relation between contractile properties and MHC isoform composition in healthy human myocardium using the diversity in atrial tissue.
Methods: Isometric force production and ATP consumption were measured in chemically skinned atrial trabeculae and ventricular muscle strips, and rate of force redevelopment was studied using single cardiomyocytes. MHC isoform composition was determined by one-dimensional SDS-gel electrophoresis.
Results: Force development in ventricular tissue was about 5-fold more economical, but nine times slower, than in atrial tissue. Significant linear correlations were found between MHC isoform composition, ATP consumption and rate of force redevelopment.
Conclusion: These results clearly indicate that even a minor shift in MHC isoform expression has considerable impact on cardiac performance in human tissue.
KEYWORDS Atrial function; Ventricular function; Contractile apparatus; Myocytes; Heart failure
Time for primary review 24 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. R. Locher, M. V. Razumova, J. E. Stelzer, H. S. Norman, J. R. Patel, and R. L. Moss Determination of rate constants for turnover of myosin isoforms in rat myocardium: implications for in vivo contractile kinetics Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H247 - H256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Moore-Morris, A. Varrault, M. E. Mangoni, A. Le Digarcher, V. Negre, C. Dantec, L. Journot, J. Nargeot, and B. Couette Identification of Potential Pharmacological Targets by Analysis of the Comprehensive G Protein-Coupled Receptor Repertoire in the Four Cardiac Chambers Mol. Pharmacol., May 1, 2009; 75(5): 1108 - 1116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Stelzer, H. S. Norman, P. P. Chen, J. R. Patel, and R. L. Moss Transmural variation in myosin heavy chain isoform expression modulates the timing of myocardial force generation in porcine left ventricle J. Physiol., November 1, 2008; 586(21): 5203 - 5214. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Hamdani, V. Kooij, S. van Dijk, D. Merkus, W. J. Paulus, C. d. Remedios, D. J. Duncker, G. J.M. Stienen, and J. van der Velden Sarcomeric dysfunction in heart failure Cardiovasc Res, March 1, 2008; 77(4): 649 - 658. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Brixius, R. Lu, B. Boelck, S. Grafweg, F. Hoyer, C. Pott, U. Mehlhorn, W. Bloch, and R. H. G. Schwinger Chronic Treatment with Carvedilol Improves Ca2+-Dependent ATP Consumption in Triton X-Skinned Fiber Preparations of Human Myocardium J. Pharmacol. Exp. Ther., July 1, 2007; 322(1): 222 - 227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. G. Daniels, T. Naya, V. L. M. Rundell, and P. P. de Tombe Development of contractile dysfunction in rat heart failure: hierarchy of cellular events Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R284 - R292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Somi, A. T. J. Klein, A. C. Houweling, J. M. Ruijter, A. A.M. Buffing, A. F.M. Moorman, and M. J.B. van den Hoff Atrial and Ventricular Myosin Heavy-chain Expression in the Developing Chicken Heart: Strengths and Limitations of Non-radioactive In Situ Hybridization J. Histochem. Cytochem., June 1, 2006; 54(6): 649 - 664. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Barth, S. Merk, E. Arnoldi, L. Zwermann, P. Kloos, M. Gebauer, K. Steinmeyer, M. Bleich, S. Kaab, M. Hinterseer, et al. Reprogramming of the Human Atrial Transcriptome in Permanent Atrial Fibrillation: Expression of a Ventricular-Like Genomic Signature Circ. Res., May 13, 2005; 96(9): 1022 - 1029. [Abstract] [Full Text] [PDF]
|
|